Cost-reduction Initiative and Financial Outlook
Important information
This presentation includes forward-looking statements including, but not limited to, statements relating to operational
and financial performance, market conditions, and other similar matters. These forward-looking statements are based
on current expectations about future events. Although the expectations described in these statements are assumed to
be reasonable, there is no guarantee that such forward-looking statements will materialize or are accurate. Since
these statements involve assumptions and estimates that are subject to risks and uncertainties, results could differ
materially from those set out in the statement. Certain of these risks and uncertainties are described further in the
Annual Report in section "Risks and uncertainties". Elekta undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise, except as required by
law or stock exchange regulations.
This presentation is intended for investors and analysts only. Some products are still in research and/or not
cleared/approved in all markets. Cancer statistics are given to show the potential market in the respective area and
does not mean that Elekta currently has products to treat these indications.
Elekta
3View entire presentation